Epivir (Lamivudine Tablets) and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Epivir (Lamivudine Tablets) and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lamivudine
Brand name: Epivir, Epivir HBV
Synonyms: Epivir
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Epivir (Lamivudine Tablets)-Insulin glargine, recombinant Subcutaneous
- Epivir (Lamivudine Tablets)-Insulin glulisine
- Epivir (Lamivudine Tablets)-Insulin Glulisine (Cartridges and Pens)
- Epivir (Lamivudine Tablets)-Insulin Glulisine (Vials)
- Epivir (Lamivudine Tablets)-Insulin glulisine Subcutaneous
- Epivir (Lamivudine Tablets)-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Epivir A/F
- Insulin glargine and lixisenatide Subcutaneous-Epivir HBV
- Insulin glargine and lixisenatide Subcutaneous-Epivir-HBV (Lamivudine Oral Solution)
- Insulin glargine and lixisenatide Subcutaneous-Epivir-HBV (Lamivudine Tablets)
- Insulin glargine and lixisenatide Subcutaneous-Eplerenone
- Insulin glargine and lixisenatide Subcutaneous-Epoetin alfa